1 |
serious adverse events
(876 times)
|
Medicine (128 times)
|
AEs (193 times) CI (103 times) RCTs (85 times)
|
1999 Adverse events in platelet apheresis donors: A multivariate analysis in a hospital-based program.
|
2 |
serious AEs
(236 times)
|
Allergy and Immunology (36 times)
|
AEs (204 times) AE (21 times) CI (17 times)
|
2002 Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS).
|
3 |
severe adverse events
(114 times)
|
Medicine (12 times)
|
AEs (16 times) OR (11 times) RR (11 times)
|
2001 Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study.
|
4 |
serious adverse effects
(11 times)
|
Toxicology (3 times)
|
CI (3 times) RCTs (3 times) ADRs (2 times)
|
2009 Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity.
|
5 |
stacked autoencoders
(8 times)
|
Science (2 times)
|
SVM (2 times) WT (2 times) AD (1 time)
|
2017 A novel framework for the identification of drug target proteins: Combining stacked auto-encoders with a biased support vector machine.
|
6 |
Staphylococcus aureus enterotoxins
(6 times)
|
Allergy and Immunology (3 times)
|
NP (2 times) CDRs (1 time) CRS (1 time)
|
2004 Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship.
|
7 |
surgical adverse events
(6 times)
|
Quality Assurance, Health Care (2 times)
|
CCI (1 time) DBS (1 time) HISPP (1 time)
|
2008 Detection of adverse events in surgical patients using the Trigger Tool approach.
|
8 |
severe AEs
(5 times)
|
Drug Therapy (1 time)
|
AEs (5 times) RR (2 times) ADA (1 time)
|
2016 Efficacy and safety of interferon-alpha2b spray in the treatment of hand, foot, and mouth disease: a multicenter, randomized, double-blind trial.
|
9 |
serious TEAEs
(4 times)
|
Neurology (3 times)
|
BRV (3 times) TEAEs (3 times) CBZ (1 time)
|
2016 Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures.
|
10 |
small-area estimates
(4 times)
|
Epidemiology (3 times)
|
COPD (1 time)
|
2012 Small area estimates of smoking prevalence in London. Testing the effect of input data.
|
11 |
smoking-attributable medical expenditures
(4 times)
|
Public Health (3 times)
|
YPLL (2 times) NICU (1 time) SAFs (1 time)
|
1998 State estimates of total medical expenditures attributable to cigarette smoking, 1993.
|
12 |
severe adverse effects
(3 times)
|
Medicine (2 times)
|
CI (2 times) RCTs (2 times) CENTRAL (1 time)
|
2012 First-line chemotherapy in low-risk gestational trophoblastic neoplasia.
|
13 |
severe asthma exacerbations
(3 times)
|
Drug-Related Side Effects and Adverse Reactions (2 times)
|
LABAs (3 times) ICSs (2 times) ED (1 time)
|
2010 Evaluating safety of long-acting beta agonists (LABAs) in patients with asthma.
|
14 |
self-assessment exercises
(2 times)
|
Photography (2 times)
|
CPD (2 times) IMI (2 times)
|
2003 Diabetic retinopathy screening.
|
15 |
serious adverse experiences
(2 times)
|
Vaccines (1 time)
|
LF (1 time) MDP (1 time) ZV (1 time)
|
2004 Report of a Scientific Working Group on Serious Adverse Events following Mectizan(R) treatment of onchocerciasis in Loa loa endemic areas.
|
16 |
single-atom electrocatalysts
(2 times)
|
Nanotechnology (2 times)
|
HER (1 time) M-N-C (1 time) OER (1 time)
|
2018 Porous Carbon-Hosted Atomically Dispersed Iron-Nitrogen Moiety as Enhanced Electrocatalysts for Oxygen Reduction Reaction in a Wide Range of pH.
|
17 |
SA episodes
(1 time)
|
Neurology (1 time)
|
NE (1 time) PVN (1 time) SA (1 time)
|
2001 Norepinephrine secretion in the hypothalamic paraventricular nucleus of rats during unlimited access to self-administered nicotine: An in vivo microdialysis study.
|
18 |
sedation adverse events
(1 time)
|
Pediatrics (1 time)
|
IQR (1 time)
|
2020 Emergency Physician-Administered Sedation for Thoracostomy in Children With Pleuropneumonia.
|
19 |
sedation-related adverse events
(1 time)
|
Gastroenterology (1 time)
|
ASAs (1 time) ERCP (1 time) MVA (1 time)
|
2016 Efficacy and Safety of Propofol-Mediated Sedation for Outpatient Endoscopic Retrograde Cholangiopancreatography (ERCP).
|
20 |
self-administration episodes
(1 time)
|
Pharmacology (1 time)
|
NE (1 time)
|
2003 Norepinephrine release in amygdala of rats during chronic nicotine self-administration: an in vivo microdialysis study.
|
21 |
self-assessment examinations
(1 time)
|
Education, Medical, Graduate (1 time)
|
---
|
2016 Predicting Performance on the American Board of Physical Medicine and Rehabilitation Written Examination Using Resident Self-Assessment Examination Scores.
|
22 |
Self-Assessment Exams
(1 time)
|
Orthopedic Procedures (1 time)
|
---
|
2018 Analysis of References Used in Orthopaedic Self-Assessment Exams.
|
23 |
serious adverse reactions
(1 time)
|
Science (1 time)
|
AEs (1 time) CBPP (1 time)
|
2018 Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP).
|
24 |
severe infusion-related adverse events
(1 time)
|
Transplantation (1 time)
|
ASCTs (1 time) PBSC (1 time) TNC (1 time)
|
2011 Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftment.
|
25 |
severe post-treatment adverse events
(1 time)
|
Tropical Medicine (1 time)
|
IVM (1 time) LF (1 time) MDA (1 time)
|
2014 Repurposed automated handheld counter as a point-of-care tool to identify individuals 'at risk' of serious post-ivermectin encephalopathy.
|
26 |
sexual alcohol expectancies
(1 time)
|
Substance-Related Disorders (1 time)
|
SMDs (1 time)
|
2014 Assessing sexual motives for drinking alcohol among HIV-positive men who have sex with men.
|
27 |
Signal-averaged electrocardiograms
(1 time)
|
Medicine (1 time)
|
DR (1 time) fQRSd (1 time) MI (1 time)
|
1995 [Body surface distribution of the signal-averaged ECG in patients with previous myocardial infarction].
|
28 |
significant adverse events
(1 time)
|
Hematology (1 time)
|
CSP (1 time) PLT (1 time) PRE (1 time)
|
2009 Improved plasma removal efficiency for therapeutic plasma exchange using a new apheresis platform.
|
29 |
silicon aerogel elastomers
(1 time)
|
Chemical Phenomena (1 time)
|
---
|
2020 Mechanically Robust and Flame-Retardant Silicon Aerogel Elastomers for Thermal Insulation and Efficient Solar Steam Generation.
|
30 |
smoking attributable expenses
(1 time)
|
Public Health (1 time)
|
NICU (1 time)
|
2011 Infant delivery costs related to maternal smoking: an update.
|
31 |
spontaneous acoustic emissions
(1 time)
|
Otolaryngology (1 time)
|
EAEs (1 time)
|
1989 The properties of spontaneous and evoked acoustic emissions in neonates and children: a preliminary report.
|
32 |
spontaneously aborted embryos
(1 time)
|
Reproductive Medicine (1 time)
|
MTHFR (1 time) TSER (1 time)
|
2008 Association between folate metabolism-related gene polymorphisms and methylation of p16(INK4A) and hMLH1 genes in spontaneously aborted embryos with normal chromosomal integrity.
|
33 |
subjective aging experiences
(1 time)
|
Social Sciences (1 time)
|
AARC (1 time)
|
2013 Natural occurrence of subjective aging experiences in community-dwelling older adults.
|
34 |
Surface-active artificial enzymes
(1 time)
|
Biomedical and Dental Materials (1 time)
|
---
|
2015 Design of Surface-Active Artificial Enzyme Particles to Stabilize Pickering Emulsions for High-Performance Biphasic Biocatalysis.
|
35 |
systemic adverse events
(1 time)
|
Immune System Diseases (1 time)
|
---
|
2014 Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety.
|